GoHealth (NASDAQ:GOCO) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS

GoHealth (NASDAQ:GOCO) released its quarterly earnings data on Monday. The company reported ($2.36) EPS for the quarter, topping the consensus estimate of ($2.40) by $0.04, FiscalAI reports. The firm had revenue of $11.91 million for the quarter, compared to the consensus estimate of $16.90 million. GoHealth had a negative return on equity of 33.29% and a negative net margin of 71.06%.

GoHealth Price Performance

NASDAQ GOCO opened at $0.86 on Tuesday. The stock has a market capitalization of $24.88 million, a PE ratio of -0.05 and a beta of 1.33. GoHealth has a 1 year low of $0.83 and a 1 year high of $7.12. The business’s 50-day moving average is $1.30 and its 200 day moving average is $2.05.

Institutional Trading of GoHealth

Several large investors have recently modified their holdings of the business. Bank of America Corp DE grew its stake in shares of GoHealth by 22.8% in the fourth quarter. Bank of America Corp DE now owns 7,831 shares of the company’s stock worth $105,000 after purchasing an additional 1,452 shares during the last quarter. Empowered Funds LLC grew its stake in shares of GoHealth by 7.7% in the first quarter. Empowered Funds LLC now owns 25,008 shares of the company’s stock worth $307,000 after purchasing an additional 1,790 shares during the last quarter. Bridgeway Capital Management LLC grew its stake in shares of GoHealth by 8.2% in the second quarter. Bridgeway Capital Management LLC now owns 27,066 shares of the company’s stock worth $150,000 after purchasing an additional 2,058 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of GoHealth by 4.3% in the second quarter. Geode Capital Management LLC now owns 118,961 shares of the company’s stock worth $660,000 after purchasing an additional 4,955 shares during the last quarter. Finally, Barclays PLC grew its stake in shares of GoHealth by 10.1% in the fourth quarter. Barclays PLC now owns 81,181 shares of the company’s stock worth $175,000 after purchasing an additional 7,430 shares during the last quarter. 24.21% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on GOCO shares. Noble Financial upgraded GoHealth to a “strong-buy” rating in a report on Wednesday, April 1st. Weiss Ratings reiterated a “sell (e+)” rating on shares of GoHealth in a report on Friday, April 24th. Finally, Freedom Capital downgraded GoHealth from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $5.00.

GoHealth Company Profile

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.